Balentine LLC’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-14,316
Closed -$175K – 626
2022
Q4
$175K Sell
14,316
-6,275
-30% -$78.2K 0.01% 550
2022
Q3
$256K Buy
+20,591
New +$360K 0.01% 427
2020
Q3
– Sell
-27
Closed -$1K – 362
2020
Q2
$1K Buy
+27
New +$596 ﹤0.01% 895

Other funds holding ELAN

Balentine LLC's ELAN Position: Q1 2023 in Review

Balentine LLC sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 14,316 shares — an estimated $175K sold.

Balentine LLC first reported a position in ELAN in Q2 2020 and held it in 3 quarters. The position peaked at $256K in Q3 2022. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Balentine LLC reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Balentine LLC sold 14,316 Elanco Animal Health shares in Q1 2023, an estimated $175K.
  • Balentine LLC first reported a position in Elanco Animal Health in Q2 2020 and held it in 3 quarters.
  • Balentine LLC's Elanco Animal Health position peaked at $256K in Q3 2022.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Balentine LLC's 13F filing for Q1 2023, filed 11 May 2023.